| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
82,783 |
59,381 |
$1.59M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
82,802 |
59,376 |
$1.59M |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
30,521 |
28,719 |
$353K |
| 81025 |
|
47,882 |
35,386 |
$211K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
9,059 |
8,342 |
$201K |
| 86592 |
|
56,325 |
42,508 |
$136K |
| 81002 |
|
43,553 |
32,080 |
$79K |
| 85018 |
|
54,645 |
40,422 |
$70K |
| 36415 |
Collection of venous blood by venipuncture |
67,942 |
52,652 |
$35K |
| 87210 |
|
12,093 |
9,449 |
$30K |
| 86780 |
|
3,428 |
2,992 |
$30K |
| 86480 |
|
667 |
525 |
$27K |
| 83655 |
|
3,512 |
2,574 |
$26K |
| 86703 |
|
830 |
783 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
247 |
183 |
$8K |
| 85027 |
|
1,449 |
1,147 |
$6K |
| 84460 |
|
1,701 |
1,340 |
$5K |
| 84450 |
|
1,705 |
1,343 |
$5K |
| 82247 |
|
1,630 |
1,276 |
$5K |
| 82565 |
|
1,419 |
1,130 |
$4K |
| 84520 |
|
1,400 |
1,112 |
$3K |
| 82948 |
|
535 |
508 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
28 |
28 |
$663.18 |
| 86580 |
|
162 |
147 |
$554.94 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
119 |
92 |
$486.87 |
| 80305 |
|
289 |
223 |
$430.92 |
| 82465 |
|
115 |
93 |
$193.38 |
| 83020 |
|
14 |
14 |
$174.79 |
| 83718 |
|
20 |
18 |
$131.56 |
| 84550 |
|
26 |
26 |
$97.68 |
| 84478 |
|
15 |
12 |
$15.51 |